INGN · Inogen Inc
United States · RS rating 48 · As of 2026-10-14
| Price | 6.13 USD |
|---|---|
| 1-day change | -3.3% |
| RS rating (overall / 1M / 3M / 12M) | 48 / 96 / 36 / 24 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 21 / 10 / 37 |
| Industry group (rank) | Medical-Products (98) |
| EPS growth Q/Q | -30.0% |
| Sales growth Q/Q | -11.6% |
| Distance from 52-week high | +31.5% |
| Market cap (USD) | $190.4M |